Total Artificial Heart Market Report 2025 (Global Edition)

Global Total Artificial Heart Market Report 2025 Market Size Split by Therapy (Bridge To Transplant, Destination Therapy, Bridge To Decision, Others), by End User (Hospitals, Clinics)

Total Artificial Heart Market Report Description

We have various report editions of Total Artificial Heart Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Total Artificial Heart Market Insights Video

Competitive Landscape of the Total Artificial Heart Market

The competitive landscape of the Total Artificial Heart (TAH) industry is dominated by a few specialized companies that are all working to improve patient outcomes, safety, and device efficacy. Leading companies like SynCardia Systems, BiVACOR, and CARMAT are in control and concentrate on technological advancements, including integrated monitoring systems, biocompatible materials, and longer battery life. To increase market presence, strategic R&D investments and collaborations with medical facilities and research institutes are typical strategies. Additionally, regional patent portfolios and regulatory standards impact competition. Due to strict regulatory standards and the demand for comprehensive clinical validation, new entrants confront significant obstacles.

In February 2024, Clinical-stage medical device manufacturer BiVACOR announced that $13 million (USD) had been granted by the Australian Government's Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support the company's Total Artificial Heart initiative and upcoming product improvements. (Source: https://bivacor.com/wp-content/uploads/2024/02/BiVACOR%C2%AE-Receives-13-Million-to-Support-Clinical-Trials-for-the-Companys-Total-Artificial-Heart-Press-Release-2.20.24.pdf) In December 2023, Aeson, a sophisticated total artificial heart, was first implanted in a patient with a heart tumor by CARMAT, the company that developed and designed it. The company's heart is a therapeutic substitute for people suffering from severe biventricular heart failure. The implant procedure was carried out in France. (Source: https://www.carmatsa.com/en/press-release/carmat-announces-the-first-implant-of-the-aeson-artificial-heart-in-a-patient-suffering-from-a-cardiac-tumor/) In March 2023, a market leader in medical technology and innovation, LivaNova PLC, announced that its Essenz Heart-Lung Machine (HLM) has been approved by the FDA under 510(k) in the United States. With FDA approval, LivaNova launched Essenz's commercialization in the United States. Additionally, Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) have approved the company's Essenz HLM. (Source: https://investor.livanova.com/news-releases/news-release-details/livanova-receives-us-fda-510k-clearance-essenz-heart-lung)

Top Companies Market Share in Total Artificial Heart Industry: (In no particular order of Rank)

• SynCardia Systems
• LLC
• CARMAT
• BiVACOR Inc.
• RealHeart
• Abbott
• ABIOMED (Johnson & Johnson Services Inc.)
• Jarvik Heart
• Inc.
• LivaNova PLC
• Getinge
• Terumo Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Total Artificial Heart Market

Which Region Will Dominate the Total Artificial Heart Market in 2024?

According to Cognitive Market Research, North America currently dominates the Total Artificial Heart market, and the region is expected to have significant growth during the projected period. High rates of heart illness, significant investment in technological advancements, and sophisticated healthcare infrastructure constitute the North American total artificial heart (TAH) industry. Increased use of TAH devices as a substitute for limited donor hearts is one of the major trends, along with developments in biocompatible materials and AI integration for better patient safety and usefulness. Numerous government and private R&D funding sources, supportive regulatory frameworks, and the growing need for long-term cardiac solutions present numerous opportunities. North America is a crucial TAH market because of partnerships with leading research institutes that speed up technological developments and the region's high rate of cardiovascular illnesses, which guarantees steady demand.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Trends in the Asia-Pacific Total Artificial Heart (TAH) industry vary by nation. Because of an aging population and rising incidence of cardiovascular disease, TAH technology is becoming more and more popular in Japan. Advanced cardiac solutions are becoming more and more in demand in China due to the country's growing healthcare infrastructure and rising disposable budgets. Because cardiac problems are becoming more common, India is seeing an increase in awareness and investment in TAH devices, especially in metropolitan areas. Strong regulatory backing and creative research projects are advantageous to Australia. Overall, TAH devices have a lot of room to expand in the region due to its diversified population and growing emphasis on cutting-edge medical technology.

The current report Scope analyzes Total Artificial Heart Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Total Artificial Heart Market Analysis

According to Cognitive Market Research, the global Total Artificial Heart market size was estimated at USD 6142.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 2457.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Total Artificial Heart market with a market size of USD 1938.57 million in 2024 and is projected to grow at a CAGR of 13.2% during the forecast period. The US has a growing need for TAH treatments since a sizable portion of the population has heart-related problems.
• The Canadian Total Artificial Heart market had a market share of USD 294.84 million in 2024 and is projected to grow at a CAGR of 14.2% during the forecast period. The prevalence of heart failure is rising due to an aging population, which is pushing up demand for TAH solutions in Canada.
• The Mexico Total Artificial Heart market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 223.59 million in 2024.

Europe Total Artificial Heart Market Analysis

According to Cognitive Market Research, the global Total Artificial Heart market size was estimated at USD 6142.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1842.75 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.7% from 2024 to 2031.

• The United Kingdom Total Artificial Heart market had a market share of USD 309.58 million in 2024 and is projected to grow at a CAGR of 14.5% during the forecast period. In the UK, demand is higher when the general public and medical professionals are more aware of the advantages of TAH.
• The France Total Artificial Heart market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 169.53 million in 2024.
• According to Cognitive Market Research, the German Total Artificial Heart market size was valued at USD 364.86 million in 2024 and is projected to grow at a CAGR of 13.9% during the forecast period. Advanced TAH device development and deployment are encouraged by Germany's reputation for engineering expertise.
• The Italy Total Artificial Heart market is projected to witness growth at a CAGR of 13.1% during the forecast period, with a market size of USD 158.48 million in 2024.
• The Russian Total Artificial Heart market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 285.63 million in 2024.
• The Spain Total Artificial Heart market is projected to witness growth at a CAGR of 12.8% during the forecast period with a market size of USD 151.11 million in 2024
• The Luxembourg Total Artificial Heart market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 57.13 million in 2024.
• The Portugal Total Artificial Heart market is projected to witness growth at a CAGR of 13.5% during the forecast period, with a market size of USD 38.70 million in 2024.
• The Greece Total Artificial Heart market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 22.11 million in 2024.
• The Rest of Europe's Total Artificial Heart market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 285.63 million in 2024.

Asia Pacific Total Artificial Heart Market Analysis

According to Cognitive Market Research, the global Total Artificial Heart market size was estimated at USD 6142.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1412.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Total Artificial Heart market size was valued at USD 635.75 million in 2024 and is projected to grow at a CAGR of 16.7% during the forecast period. Advanced heart technology investments are being driven by Chinese efforts to improve the infrastructure for cardiac care.
• The Japan Total Artificial Heart market is projected to witness growth at a CAGR of 15.7% during the forecast period, with a market size of USD 194.96 million in 2024.
• The India Total Artificial Heart market had a market share of USD 169.53 million in 2024 and is projected to grow at a CAGR of 19.0% during the forecast period. Government-private sector partnerships make it easier for cutting-edge medical innovations to be introduced in India.
• The South Korean Total Artificial Heart market is projected to witness growth at a CAGR of 16.3% during the forecast period, with a market size of USD 141.28 million in 2024.
• The Australian Total Artificial Heart market is projected to witness growth at a CAGR of 16.9% during the forecast period, with a market size of USD 73.46 million in 2024.
• The South East Asia Total Artificial Heart market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 97.48 million in 2024.
• The Rest of Asia Pacific Total Artificial Heart market is projected to witness growth at a CAGR of 17.0% during the forecast period, with a market size of USD 100.31 million in 2024.

South America Total Artificial Heart Market Analysis

According to Cognitive Market Research, the global Total Artificial Heart market size was estimated at USD 6142.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 307.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.

• According to Cognitive Market Research, Brazil's Total Artificial Heart market size was valued at USD 131.45 million in 2024 and is projected to grow at a CAGR of 15.2% during the forecast period. In Brazil, access to cutting-edge cardiac treatments is improved by ongoing healthcare system reforms.
• Argentina's Total Artificial Heart market had a market share of USD 51.60 million in 2024 and is projected to grow at a CAGR of 15.5% during the forecast period. The adoption of cutting-edge cardiac therapies is encouraged in Argentina by an emphasis on enhancing the country's healthcare infrastructure.
• Colombia's Total Artificial Heart market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 27.33 million in 2024.
• Peru's Total Artificial Heart market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 25.18 million in 2024.
• Chile's Total Artificial Heart market is projected to witness growth at a CAGR of 14.9% during the forecast period, with a market size of USD 22.11 million in 2024.
• The Rest of Latin America's Total Artificial Heart market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 49.45 million in 2024.

Middle East Total Artificial Heart Market Analysis

According to Cognitive Market Research, the global Total Artificial Heart market size was estimated at USD 6142.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 122.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.

• The GCC Countries Total Artificial Heart market is projected to witness growth at a CAGR of 15.7% during the forecast period, with a market size of USD 52.58 million in 2024. Patients looking for cutting-edge cardiac treatment choices are drawn to the GCC countries, which are developing into medical tourism destinations.
• The Egypt Total Artificial Heart market is projected to witness growth at a CAGR of 15.2% during the forecast period, with a market size of USD 12.90 million in 2024.
• The South Africa Total Artificial Heart market is projected to witness growth at a CAGR of 15.9% during the forecast period, with a market size of USD 19.41 million in 2024. There is an increased need for TAH solutions in South Africa as a result of public education campaigns on heart health and cutting-edge treatment alternatives.?
• The Turkey Total Artificial Heart market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 10.57 million in 2024.
• The Nigeria Total Artificial Heart market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 12.90 million in 2024.
• The Rest of the MEA Total Artificial Heart market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 14.50 million in 2024.

Total Artificial Heart Market Analysis

Total Artificial Heart Market Therapy Segment Analysis

According to Cognitive Market Research, Destination therapy is likely to dominate the market over the forecast period. The rising number of individuals with severe heart failure who are not candidates for heart transplantation or other treatments is the cause of this. The demand for long-term mechanical circulatory support from artificial hearts is driven by this patient population's substantial unmet medical need. Businesses are concentrating on creating next-generation artificial hearts with better functionality, like longer battery life, remote monitoring, and fewer issues linked to the device. These developments are intended to enhance patient outcomes and broaden the patient base for destination therapy (DT).

The Bridge To Transplant Therapy is the fastest-growing segment in the Total Artificial Heart Market. Patients waiting for heart transplants urgently require temporary circulatory assistance, which is driving demand for bridge-to-transplant therapy in the total artificial heart (TAH) industry. Given the scarcity of donor hearts, TAH devices are essential for end-stage heart failure patients, maintaining their condition until an appropriate donor organ becomes available. In areas with substantial transplant waiting lists and sophisticated cardiac care infrastructure, this demand is especially strong. Additionally, patient acceptance is increased as more people become aware of TAH's advantages as a workable temporary fix. Transplant demand will continue to exceed supply, and TAHs will be crucial in closing this gap.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Total Artificial Heart Industry. Request a Free Sample PDF!

Total Artificial Heart Market End User Segment Analysis

According to Cognitive Market Research, the Hospitals segment holds the largest share of the market. Total Artificial Heart (TAH) devices are in high demand in hospitals due to the rising incidence of severe heart failure and the growing acceptance of TAHs as effective therapy choices for transplant candidates. In facilities with specialized cardiac care units, TAHs provide an efficient way to manage advanced heart disease as medical professionals work to improve patient outcomes. Furthermore, hospitals are spending money on cutting-edge technology to improve the services they provide, which is driving up the use of TAH devices. Hospital demand is additionally driven by the need for excellent surgical outcomes and better patient management, which makes TAHs a crucial part of modern cardiac treatment.

In the Total Artificial Heart Market, Clinics are witnessing tremendous expansion. Increasing rates of heart disease and the necessity for more sophisticated treatment options have an impact on clinics' demand for Total Artificial Heart (TAH) systems. When it comes to treating patients with end-stage heart failure, TAHs are crucial because they provide long-term support or a bridge to a transplant as outpatient settings increase their cardiac care offerings. Clinics that specialize in cardiovascular care are more likely to use TAH technology to offer patients all-inclusive care. Furthermore, the benefits of TAHs are becoming more widely recognized by healthcare professionals, which strengthens their incorporation into clinical practice and raises demand for these devices in outpatient settings.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion